Detailed Information

Cited 2 time in webofscience Cited 2 time in scopus
Metadata Downloads

Lactoferrin-Anchored Tannylated Mesoporous Silica Nanomaterials for Enhanced Osteo-Differentiation Ability

Full metadata record
DC Field Value Language
dc.contributor.authorNoh, Sung Hyun-
dc.contributor.authorJo, Han-Saem-
dc.contributor.authorChoi, Somang-
dc.contributor.authorSong, Hee Gyeong-
dc.contributor.authorKim, Hak-Jun-
dc.contributor.authorKim, Keung Nyun-
dc.contributor.authorKim, Sung Eun-
dc.contributor.authorPark, Kyeongsoon-
dc.date.accessioned2021-08-30T04:34:44Z-
dc.date.available2021-08-30T04:34:44Z-
dc.date.created2021-06-19-
dc.date.issued2021-01-
dc.identifier.issn1999-4923-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/50224-
dc.description.abstractIn the present study, we created lactoferrin-anchored mesoporous silica nanomaterials with absorbed tannic acid (LF/TA-MSNs) and evaluated the effect of these LF/TA-MSNs on the in vitro osteo-differentiation ability of adipose-derived stem cells (ADSCs) by testing alkaline phosphatase (ALP) level, calcium accumulation, and expression of osteo-differentiation-specific genes, including osteocalcin (OCN) and osteopontin (OPN). Both bare MSNs and LF/TA-MSNs exhibited round nano-particle structures. The LF/TA-MSNs demonstrated prolonged LF release for up to 28 days. Treatment of ADSCs with LF (50 mu g)/TA-MSNs resulted in markedly higher ALP level and calcium accumulation compared to treatment with LF (10 mu g)/TA-MSNs or bare MSNs. Furthermore, LF (50 mu g)/TA-MSNs remarkably increased mRNA levels of osteo-differentiation-specific genes, including OCN and OPN, compared to MSNs or LF (10 mu g)/TA-MSNs. Together, these data suggest that the ability of LF/TA-MSNs to enhance osteo-differentiation of ADSCs make them a possible nanovehicle for bone healing and bone regeneration in patients with bone defect or disease.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherMDPI-
dc.titleLactoferrin-Anchored Tannylated Mesoporous Silica Nanomaterials for Enhanced Osteo-Differentiation Ability-
dc.typeArticle-
dc.contributor.affiliatedAuthorKim, Hak-Jun-
dc.contributor.affiliatedAuthorKim, Sung Eun-
dc.identifier.doi10.3390/pharmaceutics13010030-
dc.identifier.scopusid2-s2.0-85099961566-
dc.identifier.wosid000610685000001-
dc.identifier.bibliographicCitationPHARMACEUTICS, v.13, no.1, pp.1 - 13-
dc.relation.isPartOfPHARMACEUTICS-
dc.citation.titlePHARMACEUTICS-
dc.citation.volume13-
dc.citation.number1-
dc.citation.startPage1-
dc.citation.endPage13-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordAuthormesoporous silica nanomaterials-
dc.subject.keywordAuthorlactoferrin-
dc.subject.keywordAuthoradipose-derived stem cells-
dc.subject.keywordAuthorosteo-differentiation ability-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Hak Jun photo

Kim, Hak Jun
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE